We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Diamyd Medical: Diamyd Updates FDA IND Approval Status For Phase III Diamyd(R) Diabetes Study In The US
Diabetes Diamyd Medical (NASDAQ:DMYDY) (STO:DIAMB) announced that it has received one FDA question relating to the US Phase III IND application for DiamydŽ in treatment of type 1 diabetes. The question has been answered with additional documentation and the FDA now has 30 days to respond.
